A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.
about
Emerging Non-Canonical Functions and Regulation by p53: p53 and StemnessExploiting the p53 Pathway for Therapy.MicroRNA-141-3p promotes glioma cell growth and temozolomide resistance by directly targeting p53.Cholera Toxin Subunit B Enabled Multifunctional Glioma-Targeted Drug Delivery.Re-expression of the p53 Gene by Inhibiting the Mdm-2 Receptor in Wild-type p53 Tumors for the Treatment of Glioblastoma: A Mini Review
P2860
A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A stapled peptide antagonist o ...... atment through p53 activation.
@en
type
label
A stapled peptide antagonist o ...... atment through p53 activation.
@en
prefLabel
A stapled peptide antagonist o ...... atment through p53 activation.
@en
P2093
P2860
P1476
A stapled peptide antagonist o ...... atment through p53 activation.
@en
P2093
Jianchang Qian
Lingyu Tai
Mingfei Zhang
Xishan Chen
P2860
P356
10.1016/J.JCONREL.2015.09.061
P407
P577
2015-09-30T00:00:00Z